America’s enthusiasm for weight-loss drugs is forcing employers to drop coverage Major companies including PepsiCo, Cigna and Starbucks reportedly limiting GLP-1 coverage The Independent UK · Sep 16
How Is The Cigna Group’s Stock Performance Compared to Other Healthcare Plans CI has underperformed the broader market over the past year, despite analysts remaining moderately bullish on its future prospects. Barchart · Sep 2
How Cigna's AI chief is investing in the technology to cut costs and address some of healthcare's biggest problems Katya Andresen says AI can make healthcare more conversational, proactive, and personal for Cigna's 185 million customers. Fortune · Aug 26
Insurer rejected Rs 50 lakh claim after man’s death; consumer panel finds insurer at fault, orders full payout with 6% interest Insurer rejected Rs 50 lakh claim after man’s death: A consumer commission has directed Cigna TTK to pay Rs 50 lakh after finding that the insurer wrongly rejected a critical illness insurance claim. The insurer has also been ordered to pay interest and litigation costs, with the commission finding no… The Economic Times · Aug 14
CIOs and CTOs spent years lauding AI. Now, with costs rising, they're putting limits on how it's used After making AI tools widely accessible for employees, leaders are putting caps on usage and retraining staff to understand small and cheaper models can often do the job. Fortune · Aug 12
Are Wall Street Analysts Bullish on Cigna Group Stock? Cigna Group has lagged the broader market despite consistent earnings performance, while analysts remain moderately optimistic about its future prospects. Barchart · Aug 11
California's Continuity of Care Rules Explained After the Cigna and UC Health Standoff Ended California law allows patients in active treatment to continue seeing an out-of-network provider temporarily. Here is who qualifies and how to request it. Medical Daily · Aug 8
What to Expect From Cigna's Next Quarterly Earnings Report Cigna is scheduled to post its second-quarter results later this month, and analysts project a single-digit earnings growth. Barchart · Jul 9
Cigna invests $100 million in new AI-powered specialty pharmacy program Cigna's Evernorth has unveiled Pharmacy Forward, an AI-driven specialty pharmacy program backed by a $100 million investment. This initiative, starting with Accredo, aims to slash prescription processing times and enhance patient care by reducing clinician documentation by up to 50%. The program is set to deliver significant value, with plans… The Economic Times · Jul 1
From $18B in revenue to $275B: How CEO David Cordani transformed Cigna and chose to hand over the keys Also: All the news and watercooler chat from Fortune. Fortune · Jun 16
These 12 Fortune 500 companies have survived wars, crashes, and over 200 years of U.S. history Most companies fail within five years—but Molson Coors, Cigna, and JPMorgan Chase have survived for more than 200. Their playbook: Pick the right business—and avoid disaster. Fortune · Jun 6
Cigna Stock: Is CI Underperforming the Healthcare Sector? While Cigna has lagged behind the broader healthcare sector over the past year, Wall Street analysts remain highly bullish about the stock’s prospects. Barchart · Jun 2
Is Cigna Group Stock Underperforming the Dow? Cigna Group shows mixed price performance, yet sound fundamentals support analyst conviction for continued growth. Barchart · Feb 27
Cigna Stock: Is Wall Street Bullish or Bearish? Cigna has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects. Barchart · Feb 9
Saving Advice · Jan 18 Insurance Coverage Maps Are Being Redrawn by Zip Code If you live in a suburban neighborhood that has never seen a wildfire or a flood, you might feel safe from the “insurance crisis.” But...
Saving Advice · Jan 17 The “Ghost Network” Class Action: How to Force Your Medicare Plan to Pay for Out-of-Network Doctors in 2026 If you’ve spent your week calling “In-Network” specialists only to find out they retired three years ago or never took your insurance in the first...
Barchart · Nov 28, 2025 Is Cigna Stock Underperforming the Nasdaq? Even though Cigna has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.
Barchart · Nov 11, 2025 Cigna Group Stock: Analyst Estimates & Ratings Although Cigna Group has lagged the broader market, analysts remain bullish about its prospects.
Benzinga · Oct 30, 2025 Cigna Forecasts Two-Year Margin Strain In Pharmacy Benefit Unit, Stock Tanks Cigna Group (NYSE:CI) stock plunged after the company, during its third-quarter 2025 earnings call, said it expects margin pressure within the pharmacy benefit services segment over the next two years.
Benzinga · Sep 2, 2025 Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers Cigna Group’s (NYSE:CI) Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions, a specialty pharmacy management company.
Benzinga · Jul 31, 2025 Cigna Sees Elevated Cost Trends To Continue Into Next Year Cigna Group (NYSE:CI) reported second-quarter 2025 revenue of $67.13 billion on Thursday, beating analyst estimates of $62.46 billion.
Benzinga · Jul 25, 2025 Centene Clocks First Quarterly Loss In 13 Years, Stock Volatile (UPDATED) Editor’s Note: The story has been updated with executive comment and stock price change
Saving Advice · Jul 2, 2025 8 Insurance Companies Facing Lawsuits Over Denied Senior Claims For millions of seniors, insurance is supposed to provide peace of mind—a safety net in times of medical need, long-term care, or financial uncertainty. But...
Fortune · Jun 24, 2025 Former CEO sentenced to prison for stock trades in milestone case A lawyer for ex-Ontrak CEO and executive chairman Terren Peizer called the case a “true miscarriage of justice from the get-go.”
Barchart · Jun 3, 2025 How Is Cigna Group’s Stock Performance Compared to Other Healthcare Providers Stocks? Cigna Group has outperformed the Healthcare Providers industry over the past year, and analysts are highly optimistic about the stock’s prospects.